ECM
RMD icon

Evergreen Capital Management’s ResMed RMD Stock Holding History

Evergreen Capital Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$660K Sell
2,939
-39
-1% -$9.72K 0.01% 638
2025
Q4 		$717K Buy
2,978
+1,274
+75% +$326K 0.02% 567
2025
Q3 		$466K Sell
1,704
-41
-2% -$11.2K 0.01% 697
2025
Q2 		$450K Buy
1,745
+118
+7% +$28.1K 0.01% 607
2025
Q1 		$364K Buy
1,627
+393
+32% +$91.7K 0.01% 644
2024
Q4 		$282K Sell
1,234
-1
-0.1% -$241 0.01% 767
2024
Q3 		$301K Sell
1,235
-167
-12% -$37.3K 0.01% 712
2024
Q2 		$268K Buy
1,402
+378
+37% +$76.7K 0.01% 704
2024
Q1 		$203K Buy
+1,024
New +$188K 0.01% 797
2023
Q4 		– Sell
-1,507
Closed -$223K – 890
2023
Q3 		$223K Buy
+1,507
New +$272K 0.01% 665

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Evergreen Capital Management's RMD Position: Q1 2026 in Review

Evergreen Capital Management reduced its ResMed (RMD) stake by 1.3% in Q1 2026, selling an estimated $9.72K and leaving 2,939 shares worth $660K. The position accounts for 0.01% of the portfolio, ranked #638.

Evergreen Capital Management first reported a position in RMD in Q3 2023 and has held it in 10 quarters since. The position peaked at $717K in Q4 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Evergreen Capital Management held 2,939 shares of ResMed worth $660K as of Q1 2026.
  • Evergreen Capital Management sold 39 ResMed shares in Q1 2026, an estimated $9.72K.
  • ResMed made up 0.01% of Evergreen Capital Management's portfolio in Q1 2026, its #638 holding.
  • Evergreen Capital Management first reported a position in ResMed in Q3 2023 and has held it in 10 quarters since.
  • Evergreen Capital Management's ResMed position peaked at $717K in Q4 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Evergreen Capital Management's 13F filing for Q1 2026, filed 14 May 2026.